CoChat

Chronic oxytocin-driven alternative splicing of Crfr2α induces anxiety

Open access
Winter, Julia, Meyer, Magdalena, Berger, Ilona, Royer, Melanie, Bianchi, Marta, Kuffner, Kerstin, Peters, Sebastian, Stang, Simone, Langgartner, Dominik, Hartmann, Finn, Schmidtner, Anna K., Reber, Stefan O., Bosch, Oliver J., Bludau, Anna, Slattery, David A., van den Burg, Erwin H., Jurek, Benjamin, Neumann, Inga D. · 2023 · Molecular Psychiatry
Cited by 46

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

The neuropeptide oxytocin (OXT) has generated considerable interest as potential treatment for psychiatric disorders, including anxiety and autism spectrum disorders. However, the behavioral and molecular consequences associated with chronic OXT treatment and chronic receptor (OXTR) activation have scarcely been studied, despite the potential therapeutic long-term use of intranasal OXT. Here, we reveal that chronic OXT treatment over two weeks increased anxiety-like behavior in rats, with higher sensitivity in females, contrasting the well-known anxiolytic effect of acute OXT. The increase in anxiety was transient and waned 5 days after the infusion has ended. The behavioral effects of chronic OXT were paralleled by activation of an intracellular signaling pathway, which ultimately led to alternative splicing of hypothalamic corticotropin-releasing factor receptor 2α ( Crfr2α ), an important modulator of anxiety. In detail, chronic OXT shifted the splicing ratio from the anxiolytic membrane-bound (mCRFR2α) form of CRFR2α towards the soluble CRFR2α (sCRFR2α) form. Experimental induction of alternative splicing mimicked the anxiogenic effects of chronic OXT, while sCRFR2α-knock down reduced anxiety-related behavior of male rats. Furthermore, chronic OXT treatment triggered the release of sCRFR2α into the cerebrospinal fluid with sCRFR2α levels positively correlating with anxiety-like behavior. In summary, we revealed that the shifted splicing ratio towards expression of the anxiogenic sCRFR2α underlies the adverse effects of chronic OXT treatment on anxiety.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41380-021-01141-x

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 46

Metadata

Authors
Winter, J., Meyer, M., Berger, I., Royer, M., Bianchi, M., Kuffner, K., Peters, S., Stang, S., Langgartner, D., Hartmann, F., Schmidtner, A. K., Reber, S. O., Bosch, O. J., Bludau, A., Slattery, D. A., van den Burg, E. H., Jurek, B., & Neumann, I. D.
Venue
Molecular Psychiatry
Published
2021-05-25
Volume
28
Issue
11
Pages
4742-4755
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W3165161649
Cited by
46
References
30
FWCI
8.03
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chronic oxytocin-driven alternative splicing of Crfr2α induces anxiety. https://app.cochat.ai/papers/10.1038/s41380-021-01141-x
The paper
Winter, J., Meyer, M., Berger, I., Royer, M., Bianchi, M., Kuffner, K., Peters, S., Stang, S., Langgartner, D., Hartmann, F., Schmidtner, A. K., Reber, S. O., Bosch, O. J., Bludau, A., Slattery, D. A., van den Burg, E. H., Jurek, B., & Neumann, I. D. (2023). Chronic oxytocin-driven alternative splicing of Crfr2α induces anxiety. Molecular Psychiatry. https://doi.org/10.1038/s41380-021-01141-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.